Rockefeller Capital Management L.P.
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1739439
NEW YORK, NY
Position in ACAD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$22,868,965
-$6,860,332 QoQ
Shares Held
1,027,357
-7.7% QoQ
Ownership
0.600%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 99.93322671671095.ToString("F0")%
Shared 0.ToString("F0")%
None 0.06677328328906115.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $285,796,172 across 243 Biotechnology names. ACAD ranks #4 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
149,655 | $66,826,941 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
249,174 | $47,106,343 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
384,672 | $26,207,702 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
1,027,357 | $22,868,965 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,520 | $22,035,691 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
372,197 | $21,025,406 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
33,849 | $17,718,934 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
123,497 | $4,978,162 |
All Filings in ACAD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,868,965 | 1,027,357 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $29,729,297 | 1,113,040 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $22,114,919 | 1,036,313 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $25,115,977 | 1,164,394 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $18,903,741 | 1,138,094 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $21,349,398 | 1,163,455 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $17,532,184 | 1,139,934 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,506,561 | 954,250 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $14,578,476 | 788,452 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $17,418,910 | 556,337 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,527,804 | 505,173 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,682,721 | 404,289 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,050,160 | 480,880 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $7,381,164 | 463,641 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $7,506,458 | 458,830 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $6,132,460 | 435,235 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,695,541 | 317,735 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,060,255 | 302,496 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,671,197 | 281,228 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $5,648,333 | 231,584 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $138,339 | 5,362 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $153,322 | 2,868 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $245,932 | 5,962 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $823 | 17 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||